HomeTNXP • NASDAQ
add
Tonix Pharmaceuticals Holding Corp
Previous close
$0.46
Day range
$0.40 - $0.55
Year range
$0.40 - $32.32
Market cap
9.40M USD
Avg Volume
2.51M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 2.48M | — |
Operating expense | 22.17M | -34.60% |
Net income | -14.94M | 54.74% |
Net profit margin | -601.89 | — |
Earnings per share | -5.76 | 94.46% |
EBITDA | -20.14M | 38.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.05M | -90.21% |
Total assets | 135.34M | -24.43% |
Total liabilities | 27.20M | 99.11% |
Total equity | 108.14M | — |
Shares outstanding | 2.99M | — |
Price to book | 0.01 | — |
Return on assets | -36.84% | — |
Return on capital | -45.76% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -14.94M | 54.74% |
Cash from operations | -17.58M | 46.60% |
Cash from investing | -108.00K | 97.16% |
Cash from financing | -212.00K | 98.16% |
Net change in cash | -17.90M | 62.91% |
Free cash flow | -9.35M | 66.13% |
About
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
Founded
2007
Headquarters
Website
Employees
103